Shuttle Pharmaceuticals Holdings (SHPH) Return on Capital Employed (2022 - 2026)

Shuttle Pharmaceuticals Holdings' Return on Capital Employed history runs 5 years deep, the most recent figure standing at 394.16% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 4151.0% year-over-year to 394.16%; the TTM figure through Mar 2026 stood at 394.16% (up 4151.0% YoY), while the FY2025 annual figure was 807.51%, up 109305.0% from the prior year.
• Return on Capital Employed was 394.16% for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from 1244.66% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 1244.66% in Q4 2025 to a low of 13704.01% in Q4 2024.
• Historically, Return on Capital Employed has averaged 1662.76% across 5 years, with a median of 194.02% in 2024.
• The sharpest annual moves came in 2024 and 2025: Return on Capital Employed slumped 1359919 bps in 2024, then soared 1494866 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 29.14% in 2022, then slumped by 260 bps to 104.82% in 2023, then slumped by 12974 bps to 13704.01% in 2024, then soared by 109 bps to 1244.66% in 2025, then sank by 132 bps to 394.16% in 2026.
• The last three Return on Capital Employed figures came in at 394.16% (Q1 2026), 1244.66% (Q4 2025), and 426.21% (Q3 2025), per Business Quant data.